|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| (11) | Number of the document | 3373959 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16797775.0 |
| Date of filing the European patent application | 2016-11-04 | |
| (97) | Date of publication of the European application | 2018-09-19 |
| (45) | Date of publication and mention of the grant of the patent | 2022-06-29 |
| (46) | Date of publication of the claims translation | 2022-07-25 |
| (86) | Number | PCT/EP2016/076668 |
| Date | 2016-11-04 |
| (87) | Number | WO 2017/080920 |
| Date | 2017-05-18 |
| (30) | Number | Date | Country code |
| 201562254654 P | 2015-11-12 | US | |
| 201562254651 P | 2015-11-12 | US |
| (72) |
SCHMIDT, Sarah , AT
ORLINGER, Klaus , AT
COHEN, Katherine , AT
|
| (73) |
Hookipa Biotech GmbH ,
Helmut-Qualtinger-Gasse 2, 1030 Wien,
AT
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Arenavirusų dalelės, kaip vėžio vakcinos |
| ARENAVIRUS PARTICLES AS CANCER VACCINES |
| Payment date | Validity (years) | Amount | |
| 2025-10-29 | 10 | 231.00 EUR |
| 2026-11-04 |